Improved Drug Susceptibility Testing (DST) for Mycobacteria
Funds faster drug-susceptibility tests for tuberculosis and related mycobacterial infections that skip slow culture-based methods.
The standard way to find out which drugs a tuberculosis strain will respond to is a culture-based test, and culture is slow — slow enough that a patient can be on the wrong drug for weeks before anyone finds out. This notice funds replacing that wait.
The targets are drug susceptibility tests for mycobacterial drugs generally: drugs already used against tuberculosis and against clinically importa…
Development of rapid genotypic and improved phenotypic drug susceptibility tests, not requiring full culture growth, for mycobacterial drugs including current tuberculosis and non-tuberculous mycobacterial disease treatments, new drugs, and drugs in late-stage clinical development.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
More from NIH
All grants from this funder →GREGoRi Data Coordination and Outreach Center
🇺🇸NIH · United States
Funds the one centre that coordinates a rare-disease genomics programme and gets its protocols, data and tools out to everybody else.
GREGoRi Innovation Projects
NIH · United States
Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.
GREGoRi Technology Integration Center
🇺🇸NIH · United States
Funds the centre that turns new molecular methods for rare-disease diagnosis into standards, best practices and a benchmarking dataset.
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases
🇺🇸NIH · United States
Funds studies that watch patients rather than treat them, in bone, joint, rheumatic and skin disease. No intervention allowed.
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61)
🇺🇸NIH · United States
Funds early-stage clinical trials in arthritis, musculoskeletal and skin disease. A trial is compulsory.
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01)
NIH · United States
Funds theory and method development on how genetic and non-genetic factors together produce variation in complex traits, tested against large existing datasets.
Similar grants
Browse the directory →
CARE for Health — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports integrating clinical research into primary care environments through rural-focused network models.
NIA Alzheimer's Drug-Development Program
🇺🇸NIA · United States
Funds collaborative research alliances that accelerate Alzheimer's drug development in the United States.
Human Virome Program — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Offers exploration of the healthy human virome and virus host interactions across translational studies.
NIH Common Fund Venture Program — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports high-potential short- to medium-range initiatives that can seed major breakthroughs.
Complement-ARIE — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports development of human-based new approach methodologies replacing animal models in relevant research.
Moonshot R&D Program — Open PM and Project-Team
🇯🇵CSTI Japan · Japan
Funds disruptive Japan-wide missions in science, society, and advanced technology.